{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T13:50:57Z","timestamp":1761918657388},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2004,11,4]],"date-time":"2004-11-04T00:00:00Z","timestamp":1099526400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2004,11,4]],"date-time":"2004-11-04T00:00:00Z","timestamp":1099526400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Systemic chemotherapy is an important part of treatment for breast cancer. We conducted the present study to evaluate whether systemic chemotherapy could produce microsatellite instability (MSI) in the peripheral blood mononuclear cell fraction of breast cancer patients.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>We studied 119 sequential blood samples from 30 previously untreated breast cancer patients before, during and after chemotherapy. For comparison, we also evaluated 20 women who had no relevant medical history (control group).<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>In 27 out of 30 patients we observed MSI in at least one sample, and six patients had loss of heterozygosity. We found a significant correlation between the number of MSI events per sample and chemotherapy with alkylating agents (<jats:italic>P<\/jats:italic> &lt; 0.0001). We also observed an inverse correlation between the percentage of cells positive for hMSH2 and the number of MSI events per sample (<jats:italic>P<\/jats:italic> = 0.00019) and use of alkylating agents (<jats:italic>P<\/jats:italic> = 0.019).<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusion<\/jats:title>\n                        <jats:p>We conclude that systemic chemotherapy may induce MSI and loss of heterozygosity in peripheral blood mononuclear cells from breast cancer patients receiving alkylating agents, possibly mediated by a chemotherapy-induced decrease in the expression of hMSH2. These effects may be related to the generation of secondary leukaemia in some patients, and may also intensify the genetic instability of tumours and increase resistance to treatment.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/bcr950","type":"journal-article","created":{"date-parts":[[2004,11,6]],"date-time":"2004-11-06T07:24:44Z","timestamp":1099725884000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Systemic chemotherapy induces microsatellite instability in the peripheral blood mononuclear cells of breast cancer patients"],"prefix":"10.1186","volume":"7","author":[{"given":"Fernando LA","family":"Fonseca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra VL","family":"Sant Ana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Israel","family":"Bendit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vitor","family":"Arias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciano J","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aparecida A","family":"Pinhal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Auro","family":"del Giglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,11,4]]},"reference":[{"key":"952_CR1","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1093\/annonc\/mdg204","volume":"14","author":"C Bernard-Marty","year":"2003","unstructured":"Bernard-Marty C, Mano M, Paesmans M, Accettura C, Munoz-Bermeo R, Richard T, Kleiber K, Cardoso F, Lobelle JP, Larsimont D, et al: Second malignancies following adjuvant chemotherapy: 6-year results from a Belgian randomized study comparing cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with an anthracycline-based regimen in adjuvant treatment of node-positive breast cancer patients. Ann Oncol. 2003, 14: 693-698. 10.1093\/annonc\/mdg204.","journal-title":"Ann Oncol"},{"key":"952_CR2","doi-asserted-by":"publisher","first-page":"560","DOI":"10.7326\/0003-4819-138-7-200304010-00012","volume":"138","author":"DC Chung","year":"2003","unstructured":"Chung DC, Rustgi AK: The hereditary nonpolyposis colorectal cancer syndrome: genetics and clinical implications. Ann Intern Med. 2003, 138: 560-570.","journal-title":"Ann Intern Med"},{"key":"952_CR3","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1046\/j.1365-2141.2001.02920.x","volume":"114","author":"EP Das-Gupta","year":"2001","unstructured":"Das-Gupta EP, Seedhouse CH, Russell NH: Microsatellite instability occurs in defined subsets of patients with acute myeloblastic leukaemia. Br J Haematol. 2001, 114: 307-312. 10.1046\/j.1365-2141.2001.02920.x.","journal-title":"Br J Haematol"},{"key":"952_CR4","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1046\/j.1365-2141.2002.03458.x","volume":"117","author":"MH Sheikhha","year":"2002","unstructured":"Sheikhha MH, Tobal K, Liu Yin JA: High level of microsatellite instability but not hypermethylation of mismatch repair genes in therapy-related and secondary acute myeloid leukaemia and myelodysplastic syndrome. Br J Haematol. 2002, 117: 359-365. 10.1046\/j.1365-2141.2002.03458.x.","journal-title":"Br J Haematol"},{"key":"952_CR5","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/gcc.10059","volume":"34","author":"W Olipitz","year":"2002","unstructured":"Olipitz W, Hopfinger G, Aguiar RC, Gunsilius E, Girschikofsky M, Bodner C, Hiden K, Linkesch W, Hoefler G, Sill H: Defective DNA-mismatch repair: a potential mediator of leukemogenic susceptibility in therapy-related myelodysplasia and leukemia. Genes Chromosomes Cancer. 2002, 34: 243-248. 10.1002\/gcc.10059.","journal-title":"Genes Chromosomes Cancer"},{"key":"952_CR6","first-page":"3012","volume":"9","author":"LJ Worrillow","year":"2003","unstructured":"Worrillow LJ, Travis LB, Smith AG, Rollinson S, Smith AJ, Wild CP, Holowaty EJ, Kohler BA, Wiklund T, Pukkala E, et al: An intron splice acceptor polymorphism in hMSH2 and risk of leukemia after treatment with chemotherapeutic alkylating agents. Clin Cancer Res. 2003, 9: 3012-3020.","journal-title":"Clin Cancer Res"},{"key":"952_CR7","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1080\/0032472031000141283","volume":"1","author":"E Borgen","year":"1999","unstructured":"Borgen E, Naume B, Nesland JM, Kvalheim G, Beiske K, Fodstat O, Diel I, Solomayer E-F, Theocharous P, Coombes RC, et al: Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. Estabilishment of objective criteria for the evaluation of immunostained cells. Cytotherapy. 1999, 1: 377-388. 10.1080\/0032472031000141283.","journal-title":"Cytotherapy"},{"key":"952_CR8","first-page":"4749","volume":"57","author":"W Dietmaier","year":"1997","unstructured":"Dietmaier W, Wallinger S, Bocker T, Kullmann F, Fishel R, Ruschoff J: Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Cancer Res. 1997, 57: 4749-4756.","journal-title":"Cancer Res"},{"key":"952_CR9","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1054\/bjoc.2001.2037","volume":"85","author":"Y Watanabe","year":"2001","unstructured":"Watanabe Y, Koi M, Hemmi H, Hoshai H, Noda K: A change in microsatellite instability caused by cisplatin-based chemotherapy of ovarian cancer. Br J Cancer. 2001, 85: 1064-1069. 10.1038\/sj.bjc.6692037.","journal-title":"Br J Cancer"},{"key":"952_CR10","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1182\/blood.V94.2.733","volume":"94","author":"YM Zhu","year":"1999","unstructured":"Zhu YM, Das-Gupta EP, Russell NH: Microsatellite instability and p53 mutations are associated with abnormal expression of the MSH2 gene in adult acute leukemia. Blood. 1999, 94: 733-740.","journal-title":"Blood"},{"key":"952_CR11","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1080\/09553000110069335","volume":"77","author":"T Paunesku","year":"2001","unstructured":"Paunesku T, Mittal S, Protic M, Oryhon J, Korolev SV, Joachimiak A, Woloschak GE: Proliferating cell nuclear antigen (PCNA): ringmaster of the genome. Int J Radiat Biol. 2001, 77: 1007-1021. 10.1080\/09553000110069335.","journal-title":"Int J Radiat Biol"},{"key":"952_CR12","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3109\/10428199509107893","volume":"19","author":"A Del Giglio","year":"1995","unstructured":"Del Giglio A, Drach J, Kornblau SM, Patel S, Novaes M, Khetan R, Sawaya N, Dorlhiac-Llacer P, Chamone DF, Andreeff M: Quantitative expression of proliferating cell nuclear antigen by western blot (PCNAWB) in peripheral blasts correlates with remission induction in patients with acute myelogenous leukemia. Leuk Lymphoma. 1995, 19: 235-241.","journal-title":"Leuk Lymphoma"},{"key":"952_CR13","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3109\/10428199309148548","volume":"10","author":"A Del Giglio","year":"1993","unstructured":"Del Giglio A, O'Brien S, Ford RJ, Manning J, Saya H, Keating M, Johnston D, Chamone DF, Deisseroth AB: Proliferating cell nuclear antigen (PCNA) expression in chronic lymphocytic leukemia (CLL). Leuk Lymphoma. 1993, 10: 265-271.","journal-title":"Leuk Lymphoma"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr950.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/bcr950\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr950.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T11:01:00Z","timestamp":1728385260000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/bcr950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11,4]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2004,2]]}},"alternative-id":["952"],"URL":"https:\/\/doi.org\/10.1186\/bcr950","relation":{},"ISSN":["1465-542X"],"issn-type":[{"type":"electronic","value":"1465-542X"}],"subject":[],"published":{"date-parts":[[2004,11,4]]},"assertion":[{"value":"13 May 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2004","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2004","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2004","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R28"}}